0001193125-16-456906.txt : 20160210 0001193125-16-456906.hdr.sgml : 20160210 20160210120235 ACCESSION NUMBER: 0001193125-16-456906 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160210 DATE AS OF CHANGE: 20160210 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Invuity, Inc. CENTRAL INDEX KEY: 0001393020 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: CA FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-88891 FILM NUMBER: 161403982 BUSINESS ADDRESS: STREET 1: 444 DE HARO STREET CITY: San Francisco STATE: CA ZIP: 94107 BUSINESS PHONE: 415-655-2100 MAIL ADDRESS: STREET 1: 444 DE HARO STREET CITY: San Francisco STATE: CA ZIP: 94107 FORMER COMPANY: FORMER CONFORMED NAME: Spotlight Surgical Inc DATE OF NAME CHANGE: 20070313 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Novo A/S CENTRAL INDEX KEY: 0001388325 IRS NUMBER: 000000000 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: TUBORG HAVNEVEJ 19 CITY: HELLERUP STATE: G7 ZIP: 2900 BUSINESS PHONE: 45 8824 8824 MAIL ADDRESS: STREET 1: TUBORG HAVNEVEJ 19 CITY: HELLERUP STATE: G7 ZIP: 2900 SC 13G/A 1 d64970dsc13ga.htm SC 13G/A SC 13G/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

 

Invuity, Inc.

(Name of Issuer)

Common Stock

(Title of class of securities)

46187J 10 6

(CUSIP number)

December 31, 2015

(Date of event which requires filing of this statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

x Rule 13d-1(c)

¨ Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


SCHEDULE 13G

 

CUSIP No. 46187J 10 6   Page 2 of 5 Pages

 

1.  

Name of Reporting Person:

 

Novo A/S

2.  

Check the Appropriate Box if a Member of Group (See Instructions):

(a)  ¨        (b)  ¨

 

3.  

SEC Use Only:

 

4.  

Citizenship or Place of Organization:

 

Denmark

Number of

Shares

Beneficially

Owned By

Each

Reporting

Person With:

   5.   

Sole Voting Power:

 

925,000

   6.   

Shared Voting Power:

 

0

   7.   

Sole Dispositive Power:

 

925,000

   8.   

Shared Dispositive Power:

 

0

9.  

Aggregate Amount Beneficially Owned by Each Reporting Person:

 

925,000

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares:  ¨

 

11.  

Percent of Class Represented By Amount In Row (9):

 

7.0% (1)

12.  

Type of Reporting Person:

 

CO

 

(1) Based upon 13,306,698 shares of the Issuer’s Common Stock outstanding as of November 2, 2015, as reported by the Issuer on its Form 10-Q filed with the Securities and Exchange Commission on November 12, 2015.

 

2


SCHEDULE 13G

 

CUSIP No. 46187J 10 6   Page 3 of 5 Pages

This Amendment No. 1 amends the Schedule 13G originally filed with the Securities and Exchange Commission on June 29, 2015.

 

Item 1.

  (a)   Name of Issuer:
    Invuity, Inc.
  (b)   Address of Issuer’s Principal Executive Offices:
    444 De Haro Street
    San Francisco, California 94107

Item 2.

  (a)   Name of Person Filing:
    Novo A/S, a Danish limited liability company, is wholly owned by Novo Nordisk Fonden (the “Foundation”), a Danish commercial foundation. Novo A/S is the holding company in the group of Novo companies (currently comprised of Novo Nordisk A/S, Novozymes A/S and NNIT A/S) and is responsible for managing the Foundation’s assets, including its financial assets. Based on the governance structure of Novo A/S and the Foundation, the Foundation is not deemed to have any beneficial ownership of the securities of the Issuer held by Novo A/S.
  (b)   Address or Principal Business Office or, if none, Residence:
    Tuborg Havnevej 19
    2900 Hellerup, Denmark
  (c)   Citizenship or Place of Organization:
    Denmark
  (d)   Title of Class of Securities:
    Common Stock
  (e)   CUSIP Number:
    46187J 10 6

 

Item 3.

    If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable.

 

3


SCHEDULE 13G

 

CUSIP No. 46187J 10 6    Page 4 of 5 Pages

 

Item 4.

    Ownership:

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

(a) Amount beneficially owned:

     925,000         (1)   

(b) Percent of class:

     7.0%         (2)   

(c) Number of shares as to which such person has:

     

(i) Sole power to vote or to direct the vote:

     925,000         (1)   

(ii) Shared power to vote or to direct the vote:

     0     

(iii) Sole power to dispose or to direct the disposition of:

     925,000         (1)   

(iv) Shared power to dispose or to direct the disposition of:

     0     

 

(1) Novo A/S, through its Board of Directors (the “Novo Board”), has the sole power to vote and dispose of the shares held by Novo A/S (the “Novo Shares”). The Novo Board, currently comprised of Sten Scheibye, Goran Ando, Jeppe Christiansen, Steen Riisgaard and Per Wold-Olsen, may exercise voting and dispositive control over the Novo Shares only with the support of a majority of the Novo Board. As such, no individual member of the Novo Board is deemed to hold any beneficial ownership or reportable pecuniary interest in the Novo Shares.

 

(2) Based upon 13,306,698 shares of the Issuer’s Common Stock outstanding as of November 2, 2015, as reported by the Issuer on its Form 10-Q filed with the Securities and Exchange Commission on November 12, 2015.

 

Item 5.

    Ownership of Five Percent or Less of a Class:

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following:

 

Item 6.

    Ownership of More Than Five Percent on Behalf of Another Person:

Not applicable.

 

Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

Not applicable.

 

Item 8.

    Identification and Classification of Members of the Group:

Not applicable.

 

Item 9.

    Notice of Dissolution of Group:

Not applicable.

 

Item 10.

    Certifications:

Not applicable.

 

4


SCHEDULE 13G

 

CUSIP No. 46187J 10 6   Page 5 of 5 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 8, 2016     Novo A/S
   

/s/ Eivind Kolding

    By: Eivind Kolding
    Its: Chief Executive Officer
   

/s/ Thomas Dyrberg

    By: Thomas Dyrberg
    Its: Managing Partner
      Novo Ventures

 

5